Switch theme
Sign up to access all valuation multiples
Topchoice Medical Corp is engaged in providing medical services. The company operates as an integrated medical platform with several oral, health, and reproductive medical institutions.
1995
14
LTM Revenue $416M
LTM EBITDA $128M
$2.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Topchoice Medical has a last 12-month revenue of $416M and a last 12-month EBITDA of $128M.
In the most recent fiscal year, Topchoice Medical achieved revenue of $392M and an EBITDA of $131M.
Topchoice Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Topchoice Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $392M | $404M | XXX | XXX | XXX |
| Gross Profit | $176M | $153M | XXX | XXX | XXX |
| Gross Margin | 45% | 38% | XXX | XXX | XXX |
| EBITDA | $131M | $124M | XXX | XXX | XXX |
| EBITDA Margin | 33% | 31% | XXX | XXX | XXX |
| Net Profit | $96.8M | $75.5M | XXX | XXX | XXX |
| Net Margin | 25% | 19% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Topchoice Medical's stock price is CNY 43 (or $6).
Topchoice Medical has current market cap of CNY 19.4B (or $2.7B), and EV of CNY 20.2B (or $2.8B).
See Topchoice Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.8B | $2.7B | XXX | XXX | XXX | XXX | $0.17 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Topchoice Medical has market cap of $2.7B and EV of $2.8B.
Topchoice Medical's trades at 6.7x LTM EV/Revenue multiple, and 21.7x LTM EBITDA.
Analysts estimate Topchoice Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Topchoice Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $2.8B | XXX | XXX | XXX |
| EV/Revenue | 6.9x | XXX | XXX | XXX |
| EV/EBITDA | 22.4x | XXX | XXX | XXX |
| P/E | 36.6x | XXX | XXX | XXX |
| P/E/Growth | 2.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpTopchoice Medical's NTM/LTM revenue growth is 11%
Topchoice Medical's revenue per employee for the last fiscal year averaged $28.0M, while opex per employee averaged $3.9M for the same period.
Over next 12 months, Topchoice Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Topchoice Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Topchoice Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -5% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 42% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $28.0M | XXX | XXX | XXX | XXX |
| Opex per Employee | $3.9M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 14% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Topchoice Medical acquired XXX companies to date.
Last acquisition by Topchoice Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Topchoice Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Topchoice Medical founded? | Topchoice Medical was founded in 1995. |
| Where is Topchoice Medical headquartered? | Topchoice Medical is headquartered in China. |
| How many employees does Topchoice Medical have? | As of today, Topchoice Medical has 14 employees. |
| Is Topchoice Medical publicy listed? | Yes, Topchoice Medical is a public company listed on SHG. |
| What is the stock symbol of Topchoice Medical? | Topchoice Medical trades under 600763 ticker. |
| When did Topchoice Medical go public? | Topchoice Medical went public in 1996. |
| Who are competitors of Topchoice Medical? | Similar companies to Topchoice Medical include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Topchoice Medical? | Topchoice Medical's current market cap is $2.7B |
| What is the current revenue of Topchoice Medical? | Topchoice Medical's last 12-month revenue is $416M. |
| What is the current EBITDA of Topchoice Medical? | Topchoice Medical's last 12-month EBITDA is $128M. |
| What is the current EV/Revenue multiple of Topchoice Medical? | Current revenue multiple of Topchoice Medical is 6.7x. |
| What is the current EV/EBITDA multiple of Topchoice Medical? | Current EBITDA multiple of Topchoice Medical is 21.7x. |
| What is the current revenue growth of Topchoice Medical? | Topchoice Medical revenue growth between 2023 and 2024 was 3%. |
| Is Topchoice Medical profitable? | Yes, Topchoice Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
